https://www.stocktitan.net/sec-filings/NAMS/144-new-amsterdam-pharma-co-n-v-sec-filing-16b6a032ba8a.html
NewAmsterdam Pharma reports warrant exercise, trust resale | NAMS SEC Filing - Form 144
Mar 11, 2026 - Form 144 shows a 44,619-share warrant exercise on 03/09/2026 and The LG Lange III Trust sold 28,186 shares on 03/06/2026 for $828,849.41.
pharma reports
https://ecjobsonline.com/news/d/7073/Hengrui-Pharma-Reports-Q1-2026-Results-with-Revenue-and-Net-Profit-Growth/
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
Apr 23, 2026 - SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth i...
pharma reports
https://www.biospace.com/zosano-pharma-reports-third-quarter-2020-financial-results
Zosano Pharma Reports Third Quarter 2020 Financial Results - BioSpace
Nov 14, 2020 - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September...
pharma reportsthird quarterfinancial resultsbiospace
https://ir.cocrystalpharma.com/press-releases/detail/53/
Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update ::...
pharma reportssecond quarter
https://www.royaltypharma.com/news/royalty-pharma-reports-first-quarter-2021-results/
Royalty Pharma Reports First Quarter 2021 Results | Royalty Pharma
Dec 13, 2023 - NEW YORK , May 11, 2021 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2021 and raised full-year 2021 guidance...
pharma reportsfirst quarterroyaltyresults
https://www.globenewswire.com/news-release/2026/03/26/3263396/0/en/SpyGlass-Pharma-Reports-Fourth-Quarter-and-Full-Year-2025-Earnings-and-Provides-a-Corporate-Update.html
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025
Successfully completed Initial Public Offering (IPO) in February 2026, raising $172.5 million and listing on Nasdaq.Reported positive topline 12-month data...
pharma reportsfull yearfourthquarter
https://glance.eyesoneyecare.com/stories/2025-04-28/spyglass-pharma-reports-positive-18-month-data-on-glaucoma-sustained-delivery-system/
SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system
Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.
pharma reports
https://hongkongtechpress.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Hong Kong Tech Press
ascendis pharmafirst quarter
https://goldenstatenewswire.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Golden State Newswire
Golden State Newswire is an online news publication focusing on the California: The latest news from California
ascendis pharmafirst quarterfinancial resultsgolden statereports
https://www.pharmaindustrial-india.com/news/gland-pharma-reports-revenue-of-inr-14058-million-in-q2fy25
Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25 - Global Pharma
Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25 - Global Pharma
pharma reports
https://valeopharma.com/valeo-pharma-reports-record-third-quarter-2023-revenues/
VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUES - Valeo Pharma
Sep 13, 2023 - Seventh consecutive quarter of revenue growth at $14.1 million in Q3-23, up 132% over Q3-22. Physicians prescribing Enerzair and Atectura reached 2,503 at the...
pharma reportsthird quartervaleorecordrevenues
https://ir.cocrystalpharma.com/press-releases/detail/45
Cocrystal Pharma Reports 2017 Financial Results and Provides Corporate Overview and Business...
pharma reportsfinancial resultscorporate overview
https://sciencepressreleases.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Science Press Releases
ascendis pharmafirst quarterfinancial resultsreports
https://ir.cocrystalpharma.com/press-releases/detail/188
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral...
pharma reportsfinancial results
https://www.pharma-reports.com/
Pharma Reports | Data Insights & Market Analytics
Access real-time pharmaceutical market analytics, performance insights, and data reports through Pharma Reports by Base44.
pharma reportsdata insightsmarketanalytics
https://business.woonsocketcall.com/woonsocketcall/article/gnwcq-2025-11-7-newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4
User | woonsocketcall.com - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
pharma reports
https://hawaiihealthdigest.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Hawaii Health Digest
ascendis pharmafirst quarterfinancial resultsreports
https://www.businesstimesmissouri.com/article/910785120-royalty-pharma-reports-first-quarter-2026-results
Royalty Pharma reports first quarter 2026 results | Business Times of Missouri
pharma reportsfirst quarterbusiness timesroyalty
https://healthobserverbermuda.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Health Observer Bermuda
ascendis pharmafirst quarterfinancial resultsreports
https://iraqhealthcarewire.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results
Ascendis Pharma Reports First Quarter 2026 Financial Results | Iraq Healthcare Wire
ascendis pharmafirst quarterfinancial resultsreports
https://www.uscultureandstyle.com/article/910785120-royalty-pharma-reports-first-quarter-2026-results
Royalty Pharma reports first quarter 2026 results | US Culture & Style Today
pharma reportsfirst quarterroyalty
https://latammediareport.com/article/910785120-royalty-pharma-reports-first-quarter-2026-results
Royalty Pharma reports first quarter 2026 results | The LATAM Media Report
pharma reportsfirst quarterroyalty
https://ec2-13-251-157-120.ap-southeast-1.compute.amazonaws.com/flash-news/earnings-call-royalty-pharma-reports-robust-q3-growth-raises-guidance/
Earnings call: Royalty Pharma reports robust Q3 growth, raises guidance - Trade Savi
Nov 6, 2024 - Royalty Pharma plc (NASDAQ: RPRX) delivered a strong performance in the third quarter of 2024, with significant increases in Portfolio and Royalty Receipts
earnings callpharma reports
https://www.stocktitan.net/sec-filings/NAMS/144-new-amsterdam-pharma-co-n-v-sec-filing-16b6a032ba8a.html
NewAmsterdam Pharma reports warrant exercise, trust resale | NAMS SEC Filing - Form 144
Mar 11, 2026 - Form 144 shows a 44,619-share warrant exercise on 03/09/2026 and The LG Lange III Trust sold 28,186 shares on 03/06/2026 for $828,849.41.
pharma reports
https://investor.igcpharma.com/igc-reports-financial-results-for-the-quarter-ended-june-30-2019/
IGC Reports Financial Results for the Quarter Ended June 30, 2019 - IGC Pharma, INC.
May 23, 2024 - Facebook Twitter LinkedIn View File Facebook Twitter LinkedIn Related Posts CEO Update
https://www.missionir.com/lantern-pharma-inc-ltrn/lantern-pharma-inc-nasdaq-ltrn-reports-q2-results-with-clinical-trial-ai-platform-advancements/
Lantern Pharma Inc. (NASDAQ: LTRN) Reports Q2 Results with Clinical Trial, AI Platform Advancements...
Aug 25, 2025 - Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug...
https://ecjobsonline.com/news/d/7073/Hengrui-Pharma-Reports-Q1-2026-Results-with-Revenue-and-Net-Profit-Growth/
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
Apr 23, 2026 - SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth i...
pharma reports
https://puertoricotechnologytoday.com/article/911062265-newamsterdam-pharma-provides-corporate-update-and-reports-first-quarter-financial-results
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results | Puerto...
corporate update
https://www.biospace.com/zosano-pharma-reports-third-quarter-2020-financial-results
Zosano Pharma Reports Third Quarter 2020 Financial Results - BioSpace
Nov 14, 2020 - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September...
pharma reportsthird quarterfinancial resultsbiospace
https://ir.cocrystalpharma.com/press-releases/detail/205/
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral...
https://technologydigestyemen.com/article/911062265-newamsterdam-pharma-provides-corporate-update-and-reports-first-quarter-financial-results
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results |...
corporate updatefirst quarterpharmaprovides
https://nevadabusinessherald.com/article/855043056-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | Nevada Business...
https://pharmaindustryreports.com/tag/bio-plasticizer-market-forecast/
Bio Plasticizer Market Forecast Archives - Pharma Industry Reports
market forecastpharma industrybioplasticizerarchives
https://pharmaindustryreports.com/tag/foot-and-mouth-disease-fmd-vaccines-market-past-data/
Foot and Mouth Disease (FMD) Vaccines Market Past Data Archives - Pharma Industry Reports
foot and mouth disease
https://ir.cocrystalpharma.com/press-releases/detail/53/
Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update ::...
pharma reportssecond quarter